Russell Investments Group’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.2K | Sell |
2,736
-39,063
| -93% | -$375K | ﹤0.01% | 3133 |
|
|
2025
Q1 | $262K | Buy |
+41,799
| New | +$262K | ﹤0.01% | 2511 |
|
|
2024
Q4 | – | Sell |
-36
| Closed | -$651 | – | 3773 |
|
|
2024
Q3 | $651 | Sell |
36
-484
| -93% | -$8.75K | ﹤0.01% | 3534 |
|
|
2024
Q2 | $5.36K | Buy |
+520
| New | +$5.36K | ﹤0.01% | 3197 |
|
|
2024
Q1 | – | Sell |
-39,292
| Closed | -$359K | – | 3352 |
|
|
2023
Q4 | $359K | Buy |
39,292
+25,172
| +178% | +$230K | ﹤0.01% | 2315 |
|
|
2023
Q3 | $146K | Buy |
14,120
+5,139
| +57% | +$53.3K | ﹤0.01% | 2548 |
|
|
2023
Q2 | $129K | Buy |
+8,981
| New | +$129K | ﹤0.01% | 2554 |
|
|
2022
Q2 | – | Sell |
-575
| Closed | -$7K | – | 2951 |
|
|
2022
Q1 | $7K | Sell |
575
-8,788
| -94% | -$107K | ﹤0.01% | 2724 |
|
|
2021
Q4 | $183K | Sell |
9,363
-3,123
| -25% | -$61K | ﹤0.01% | 2740 |
|
|
2021
Q3 | $400K | Sell |
12,486
-190
| -1% | -$6.09K | ﹤0.01% | 2553 |
|
|
2021
Q2 | $428K | Buy |
+12,676
| New | +$428K | ﹤0.01% | 2661 |
|